| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (G.A.K., V.S.L., M.T.N., N.M.R., J.C.W.), Pathology (N.D.T.), and Transplantation (G.R.M., L.W.T.) and the Kaplan Comprehensive Cancer Center (G.A.K., N.D.T.), New York University Medical Center, 530 First Ave, New York, NY 10016. Received March 7, 2000; revision requested April 25; revision received May 25; accepted June 5. G.A.K. supported by an RSNA Seed Grant. Address correspondence to G.A.K. (e-mail: glenn.krinsky@med.nyu.edu).
PURPOSE: To determine the sensitivity of magnetic resonance (MR) imaging for detection of siderotic nodules in patients with cirrhosis and whether the frequency of hepatocellular carcinoma (HCC) and dysplastic nodules is greater if siderotic nodules are present.
MATERIALS AND METHODS: MR imaging (1.5 T) was performed within 0–117 days (mean, 30 days) before liver transplantation in 77 patients. Two readers retrospectively evaluated gradient-echo (GRE) (echo time [TE], 
9 and 4–5 msec) and turbo short inversion time inversion-recovery or T2-weighted images for low-signal-intensity nodules. Whole-explant pathologic correlation was available in every case.
RESULTS: At explantation, 28 (36%) of 77 patients had HCC, 25 (32%) had dysplastic nodules, and nine (12%) had both; 35 (45%) patients had siderotic nodules. The sensitivity of GRE imaging with 9-msec or longer TE for the detection of siderotic nodules was 80% (28 of 35) but decreased to 31% (11 of 35) with 4–5-msec TE. Frequency of HCC was not significantly higher (P = .27) in patients with (43% [15 of 35]) than in patients without (31% [13 of 42]) siderotic nodules. Frequency of dysplastic nodules also was not significantly higher (P = .42) in patients with (37% [13 of 35]) than in patients without (29% [12 of 42]) siderotic nodules.
CONCLUSION: Sensitivity of MR imaging for the detection of siderotic nodules was improved with use of GRE pulse sequences with longer TEs of 9 msec or greater (80%) versus 4–5 msec (31%); however, there was no significant increased frequency of HCC or dysplastic nodules in patients with pathologically proved siderotic nodules.
Index terms: Liver, cirrhosis, 761.794 • Liver, MR, 761.121412, 761.121413 • Liver, nodules • Liver, transplantation, 761.45 • Liver neoplasms, 761.32
This article has been cited by other articles:
|
|
 |
|
  J. M. Willatt, H. K. Hussain, S. Adusumilli, and J. A. Marrero MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies Radiology, May 1, 2008; 247(2): 311 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Parikh, S. J. Drew, V. S. Lee, S. Wong, E. M. Hecht, J. S. Babb, and B. Taouli Focal Liver Lesion Detection and Characterization with Diffusion-weighted MR Imaging: Comparison with Standard Breath-hold T2-weighted Imaging Radiology, March 1, 2008; 246(3): 812 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Krinsky and G. Israel Nondysplastic Nodules That Are Hyperintense on T1-Weighted Gradient-Echo MR Imaging: Frequency in Cirrhotic Patients Undergoing Transplantation Am. J. Roentgenol., April 1, 2003; 180(4): 1023 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Baron and M. S. Peterson From the RSNA Refresher Courses: Screening the Cirrhotic Liver for Hepatocellular Carcinoma with CT and MR Imaging: Opportunities and Pitfalls RadioGraphics, October 1, 2001; 21(90001): S117 - 132. [Abstract] [Full Text] [PDF]
|
|
